Showing results (21-30 of 136) with videos related to
Sort By:
Pageof 14
Diagnostic Microbiology and Infectious Disease|August 1, 1996
Antimicrobial resistance issues of the futureW A CraigScandinavian Journal of Infectious Diseases. Supplementum|January 1, 1993
The pharmacokinetics of cefpirome--rationale for a twelve-hour dosing regimenW A CraigInternational Journal of Antimicrobial Agents|January 1, 1995
Kinetics of antibiotics in relation to effective and convenient outpatient parenteral therapyW A CraigDiagnostic Microbiology and Infectious Disease|March 1, 1993
Qualitative susceptibility tests versus quantitative MIC testsW A CraigAntimicrobial Agents and Chemotherapy|July 16, 2008
In vivo pharmacodynamic target investigation for micafungin against Candida albicans and C. glabrata in a neutropenic murine candidiasis modelD R Andes, D J Diekema, M A Pfaller, et al.Fungal Genetics and Biology : FG & B|August 9, 2011
Application of the systematic "DAmP" approach to create a partially defective C. albicans mutantJ S Finkel, N Yudanin, J E Nett, et al.Antimicrobial Agents and Chemotherapy|April 6, 2016
In Vivo Pharmacodynamic Target Investigation of Two Bacterial Topoisomerase Inhibitors, ACT-387042 and ACT-292706, in the Neutropenic Murine Thigh Model against Streptococcus pneumoniae and Staphylococcus aureusA J Lepak, P Seiler, J P Surivet, et al.Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1978
Theory and practical impact of binding of antimicrobials to serum proteins and tissueW A Craig, B SuhThe American Journal of Medicine|July 31, 1984
Changing patterns of hospital infections: implications for therapy. Changing concepts and new applications of antibiotic pharmacokineticsW A Craig, B VogelmanSeminars in Respiratory Infections|January 22, 1998
Aminoglycosides are useful for severe respiratory tract infectionsW A Craig, D AndesPageof 14